Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Quest Pharmatech Inc
V.QPT
Alternate Symbol(s):
QPTFF
Healthcare
Biotechnology
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest...
Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:QPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
(98)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jan 15, 2024 6:59am
RE:Interesting
ARIMA11, honestly do you find this deal is getting more and more convoluted as time passes? Will QPT shareholders ever see any monetary benefits? G1945V
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Jan 14, 2024 9:08pm
Interesting
https://canariabio.com/eng/rnd/pipeline.php https://canariabio.com/eng/about/ceo.php#greeting
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
posted May 08, 2024 9:00am by
Numinus Wellness Inc
-
|
"We are excited to enter this next stage of our development, which sharpens our focus on expanding access to psychedelic-assisted therapies and accelerates our path to profitability. We aim to empower a broader community of drug developers and healthcare providers by optimizing our therapy, research, and training expertise. This strategic focus is about bringing transformative treatments ...read more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Jan 05, 2024 1:33pm
Interesting
From most recent MD&A Quest’s funding needs will vary as its drug development products move into and through clinical trials. Based on current operating budgets, management believes that the
...more
(98)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Jan 05, 2024 5:25am
Q&A with Pierre Vermette
I feel it's important to post this information which may help explain somewhat the financials of Oct 2023. Q1: Could you please clarify the reason why the Financials of Oct 2023 only
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Dec 20, 2023 8:20pm
Interesting
iA Private Wealth Inc (76) is a buyer... Date Time Price Size Conditions Buyer ID Seller ID DEC 20 03:17:50 PM 0.07 41,000 76 19 DEC 20 03:17:08 PM 0.065 5,000 76 1 DEC 20 03:17:08 PM 0.065
...more
(98)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 23, 2023 8:05am
RE:RE:RE:Interesting
OPPS! I missed the first tranche of $22,291,000 was paid out immediately assuming that being May 2023?? So where is our 42.5 % of the $22,291,000 interest in OncoQuest sitting
...more
(98)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 23, 2023 7:42am
RE:RE:Interesting
"The cash is receivable in 3 tranches (immediately – 21.6 billion KRW ($22,291,000), end of December 2023 – 25.9 billion KRW ($26,728,600) and end of June 2024 – 30.0 billion KRW ($30,959,800
...more
(98)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 23, 2023 7:18am
RE:RE:Interesting
The original deal was for U.S. $ 300 million in a combination of Dual common stock and Dual perpetual convertible bonds. Why has this dwindled down to only $79,979,000 in cash and $66,700,000 in bonds
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Comment by
ARIMA11
on Sep 22, 2023 3:17pm
RE:Interesting
i) Correction: It Iooks like OncoQuest got some... cash: In return, OncoQuest received US$125 million of OQP Korea bonds convertible into OQP Korea shares, US$8.4 million in cash, and an OQP Korea
...more
(98)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Sep 20, 2023 6:18am
RE:Interesting
Hoping that the largest shareholder of QPT, "Shenzhen Hepalink Pharmaceutical Group Co. Ltd " with a 15% ownership will jump in and stir the ship for Madiyalakan because he sucks at
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Sep 18, 2023 3:40pm
Interesting
https://ceo.ca/@newswire/quest-pharmatech-provides-corporate-update-e1c0d The assets transfer could be a good "how not to" case for business schools. Three years plus after the sale not a
...more
(38)
•••
ARIMA11
X
View Profile
View Bullboard History
Post by
ARIMA11
on Sep 05, 2023 1:31pm
Interesting
CEO is buying at the open market... https://ceo.ca/qpt?23cb45f8a96a
(98)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Jul 13, 2023 11:40am
Annual general meeting today July 13, 2023
Meeting time 11 AM Edmonton time: 1 PM Toronto Time (EST) Shareholders can also participate in the meeting via teleconference. Does anyone know how we connect via teleconference? G1945V
(1893)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jul 11, 2023 1:23am
Patent granted
https://www.newswire.ca/news-releases/quest-pharmatech-provides-product-development-update-881782265.html
(98)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Jun 21, 2023 7:44am
RE:RE:New Press Release - Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.
If things go according to Hoyle financially in accordance with the latest annual financials, the book value share price calculates to approximately 50 cents Cdn. The current market value share price
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share